$8.60
-0.06[-0.69%]
At close: Apr 18
$8.60
0[0.00%]
After Hours: 4:00PM EDT
Bausch Health Companies
(NYSE:BHC)Bausch Health Companies Stock (NYSE:BHC), Analyst Ratings, Price Targets, Predictions
Bausch Health Companies Inc has a consensus price target of $6, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, RBC Capital, and RBC Capital on April 12, 2024, April 5, 2024, and February 23, 2024. With an average price target of $11 between RBC Capital, RBC Capital, and RBC Capital, there's an implied 27.91% upside for Bausch Health Companies Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Jefferies
TD Cowen
Piper Sandler
BMO Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Bausch Health Companies
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | BHC | Buy Now | Bausch Health Companies | $8.60 | 39.53% | RBC Capital | Douglas Miehm | → $12 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/05/2024 | BHC | Buy Now | Bausch Health Companies | $8.60 | 39.53% | RBC Capital | Douglas Miehm | $9 → $12 | Maintains | Sector Perform | Get Alert |
| 02/23/2024 | BHC | Buy Now | Bausch Health Companies | $8.60 | 4.65% | RBC Capital | Douglas Miehm | $8 → $9 | Maintains | Sector Perform | Get Alert |
| 09/20/2023 | BHC | Buy Now | Bausch Health Companies | $8.60 | 86.05% | Jefferies | David Steinberg | $9 → $16 | Upgrade | Hold → Buy | Get Alert |
| 06/16/2023 | BHC | Buy Now | Bausch Health Companies | $8.60 | — | TD Cowen | Ken Cacciatore | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/22/2023 | BHC | Buy Now | Bausch Health Companies | $8.60 | 10.47% | Jefferies | David Steinberg | $7 → $9.5 | Maintains | Buy | Get Alert |
| 05/05/2023 | BHC | Buy Now | Bausch Health Companies | $8.60 | -6.98% | RBC Capital | Douglas Miehm | $9 → $8 | Maintains | Sector Perform | Get Alert |
| 09/09/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | -30.23% | Piper Sandler | David Amsellem | $7 → $6 | Maintains | Neutral | Get Alert |
| 09/01/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | -6.98% | RBC Capital | Douglas Miehm | $4.5 → $8 | Maintains | Sector Perform | Get Alert |
| 08/10/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | -6.98% | BMO Capital | Gary Nachman | $15 → $8 | Maintains | Market Perform | Get Alert |
| 08/10/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | -47.67% | RBC Capital | Douglas Miehm | $5 → $4.5 | Maintains | Sector Perform | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | -41.86% | RBC Capital | Douglas Miehm | $12 → $5 | Downgrade | Outperform → Sector Perform | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | — | JP Morgan | Chris Schott | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | — | Truist Securities | Gregory Fraser | — | Downgrade | Buy → Hold | Get Alert |
| 07/26/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | 39.53% | RBC Capital | Douglas Miehm | $17 → $12 | Maintains | Outperform | Get Alert |
| 06/13/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | 39.53% | JP Morgan | Chris Schott | → $12 | Reinstates | → Overweight | Get Alert |
| 05/13/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | 97.67% | RBC Capital | Douglas Miehm | $21 → $17 | Maintains | Outperform | Get Alert |
| 05/09/2022 | BHC | Buy Now | Bausch Health Companies | $8.60 | 144.19% | RBC Capital | Douglas Miehm | $32 → $21 | Maintains | Outperform | Get Alert |
| 11/03/2021 | BHC | Buy Now | Bausch Health Companies | $8.60 | 365.12% | RBC Capital | Douglas Miehm | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Bausch Health Companies (BHC)?
The latest price target for Bausch Health Companies (NYSE: BHC) was reported by RBC Capital on April 12, 2024. The analyst firm set a price target for $12.00 expecting BHC to rise to within 12 months (a possible 39.53% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bausch Health Companies (BHC)?
The latest analyst rating for Bausch Health Companies (NYSE: BHC) was provided by RBC Capital, and Bausch Health Companies reiterated their sector perform rating.
When was the last upgrade for Bausch Health Companies (BHC)?
The last upgrade for Bausch Health Companies Inc happened on September 20, 2023 when Jefferies raised their price target to $16. Jefferies previously had a hold for Bausch Health Companies Inc.
When was the last downgrade for Bausch Health Companies (BHC)?
The last downgrade for Bausch Health Companies Inc happened on June 16, 2023 when TD Cowen changed their price target from N/A to N/A for Bausch Health Companies Inc.
When is the next analyst rating going to be posted or updated for Bausch Health Companies (BHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch Health Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch Health Companies was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Bausch Health Companies (BHC) correct?
While ratings are subjective and will change, the latest Bausch Health Companies (BHC) rating was a reiterated with a price target of $0.00 to $12.00. The current price Bausch Health Companies (BHC) is trading at is $8.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.